Data / Form D filings / CELESTIAL THERAPEUTICS INC.
CELESTIAL THERAPEUTICS INC.: Form D filings
CELESTIAL THERAPEUTICS INC., a biotechnology company in Irvine, CA, filed 33 Form D notices with the SEC between 2020 and 2026. The latest, on July 6, 2026, reports $850,000 sold of an offering with no set size to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4790 IRVINE BLVD., SUITE 105332, Irvine, CA, 92620
- Phone
- (949) 402-2388
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1804448
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Amendment | Indefinite | $850,000 | 11 | Sep 3, 2024 | sec.gov | |
| Oct 9, 2025 | Amendment | Indefinite | $800,000 | 10 | Sep 3, 2024 | sec.gov | |
| Jun 23, 2025 | Amendment | Indefinite | $775,000 | 9 | Sep 3, 2024 | sec.gov | |
| May 21, 2025 | Amendment | Indefinite | $725,000 | 8 | Sep 3, 2024 | sec.gov | |
| May 8, 2025 | Amendment | Indefinite | $625,000 | 8 | Apr 21, 2025 | sec.gov | |
| Apr 25, 2025 | Amendment | Indefinite | $575,000 | 7 | Apr 21, 2025 | sec.gov | |
| Apr 7, 2025 | Amendment | Indefinite | $550,000 | 6 | Sep 3, 2024 | sec.gov | |
| Mar 27, 2025 | Amendment | Indefinite | $500,000 | 5 | Sep 3, 2024 | sec.gov | |
| Feb 13, 2025 | Amendment | Indefinite | $400,000 | 4 | Sep 3, 2024 | sec.gov | |
| Jan 23, 2025 | Amendment | Indefinite | $300,000 | 3 | Sep 3, 2024 | sec.gov | |
| Sep 10, 2024 | New notice | Indefinite | $100,000 | 1 | Sep 3, 2024 | sec.gov | |
| Apr 11, 2024 | Amendment | Indefinite | $1,339,224 | 13 | Mar 31, 2020 | sec.gov | |
| Mar 21, 2024 | Amendment | Indefinite | $1,230,000 | 12 | Mar 31, 2020 | sec.gov | |
| Jun 23, 2023 | Amendment | $1,130,000 | $1,130,000 | 12 | Mar 31, 2020 | sec.gov | |
| Jun 1, 2023 | Amendment | Indefinite | $1,085,000 | 11 | Mar 31, 2020 | sec.gov | |
| May 5, 2023 | Amendment | Indefinite | $1,035,000 | 11 | Mar 31, 2020 | sec.gov | |
| Apr 24, 2023 | Amendment | Indefinite | $1,010,000 | 11 | Mar 31, 2020 | sec.gov | |
| Jul 28, 2022 | Amendment | Indefinite | $910,000 | 11 | Mar 31, 2020 | sec.gov | |
| Jul 14, 2022 | Amendment | Indefinite | $890,000 | 11 | Mar 31, 2020 | sec.gov | |
| Feb 10, 2022 | Amendment | Indefinite | $865,000 | 10 | Mar 31, 2020 | sec.gov | |
| Jan 6, 2022 | Amendment | Indefinite | $680,000 | 9 | Mar 31, 2020 | sec.gov | |
| Dec 22, 2021 | Amendment | Indefinite | $630,000 | 9 | Mar 31, 2020 | sec.gov | |
| Sep 24, 2021 | Amendment | Indefinite | $580,000 | 9 | Mar 31, 2020 | sec.gov | |
| Sep 3, 2021 | Amendment | Indefinite | $480,000 | 9 | Mar 31, 2020 | sec.gov | |
| Mar 25, 2021 | Amendment | $500,000 | $430,000 | $70,000 | 9 | Mar 31, 2020 | sec.gov |
| Feb 18, 2021 | Amendment | $500,000 | $410,000 | $90,000 | 8 | Mar 31, 2020 | sec.gov |
| Jan 27, 2021 | Amendment | $500,000 | $310,000 | $190,000 | 7 | Mar 31, 2020 | sec.gov |
| Dec 17, 2020 | Amendment | $500,000 | $230,000 | $270,000 | 6 | Mar 31, 2020 | sec.gov |
| Sep 21, 2020 | Amendment | $500,000 | $210,000 | $290,000 | 6 | Mar 31, 2020 | sec.gov |
| Jul 31, 2020 | Amendment | $500,000 | $195,000 | $305,000 | 6 | Mar 31, 2020 | sec.gov |
| Jun 15, 2020 | Amendment | $500,000 | $135,000 | $365,000 | 5 | Mar 31, 2020 | sec.gov |
| Apr 17, 2020 | Amendment | $500,000 | $115,000 | $385,000 | 4 | Mar 31, 2020 | sec.gov |
| Apr 9, 2020 | New notice | $500,000 | $25,000 | $475,000 | 1 | Mar 31, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ajay Gupta | Executive Officer, Director | President, CEO and Chairman of the Board |
| George Siber | Director | |
| Leontis Teryazos | Executive Officer, Director | CFO and Corporate Secretary |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 6, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CELESTIAL THERAPEUTICS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.